These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38601165)

  • 1. Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells.
    Lamendour L; Gilotin M; Deluce-Kakwata Nkor N; Lakhrif Z; Meley D; Poupon A; Laboute T; di Tommaso A; Pin JJ; Mulleman D; Le Mélédo G; Aubrey N; Watier H; Velge-Roussel F
    Front Immunol; 2024; 15():1369117. PubMed ID: 38601165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.
    Jaen O; Rullé S; Bessis N; Zago A; Boissier MC; Falgarone G
    Immunology; 2009 Jan; 126(1):35-44. PubMed ID: 18754812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR2-dependent activation of β-catenin pathway in dendritic cells induces regulatory responses and attenuates autoimmune inflammation.
    Manoharan I; Hong Y; Suryawanshi A; Angus-Hill ML; Sun Z; Mellor AL; Munn DH; Manicassamy S
    J Immunol; 2014 Oct; 193(8):4203-13. PubMed ID: 25210120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role of plasmacytoid dendritic cells in humans: induction of interleukin-10-producing Treg cells by plasmacytoid dendritic cells in patients with rheumatoid arthritis responding to therapy.
    Kavousanaki M; Makrigiannakis A; Boumpas D; Verginis P
    Arthritis Rheum; 2010 Jan; 62(1):53-63. PubMed ID: 20039433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Lectin-EGF antibody promotes regulatory T cells and attenuates nephrotoxic nephritis via DC-SIGN on dendritic cells.
    Cai M; Wu J; Mao C; Ren J; Li P; Li X; Zhong J; Xu C; Zhou T
    J Transl Med; 2013 Apr; 11():103. PubMed ID: 23627732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tethering Innate Surface Receptors on Dendritic Cells: A New Avenue for Immune Tolerance Induction?
    Lamendour L; Deluce-Kakwata-Nkor N; Mouline C; Gouilleux-Gruart V; Velge-Roussel F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retargeting of human regulatory T cells by single-chain bispecific antibodies.
    Koristka S; Cartellieri M; Theil A; Feldmann A; Arndt C; Stamova S; Michalk I; Töpfer K; Temme A; Kretschmer K; Bornhäuser M; Ehninger G; Schmitz M; Bachmann M
    J Immunol; 2012 Feb; 188(3):1551-8. PubMed ID: 22184723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features.
    Rutella S; Bonanno G; Procoli A; Mariotti A; de Ritis DG; Curti A; Danese S; Pessina G; Pandolfi S; Natoni F; Di Febo A; Scambia G; Manfredini R; Salati S; Ferrari S; Pierelli L; Leone G; Lemoli RM
    Blood; 2006 Jul; 108(1):218-27. PubMed ID: 16527888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of a bispecific antibody targeting TNF-α and C5a in Pichia pastoris and its therapeutic potential in rheumatoid arthritis.
    Chen J; He Z; Fan Y; Zhou X; Li L; Liu M
    Biotechnol Lett; 2020 Apr; 42(4):557-569. PubMed ID: 32040674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance.
    Castenmiller C; Keumatio-Doungtsop BC; van Ree R; de Jong EC; van Kooyk Y
    Front Immunol; 2021; 12():643240. PubMed ID: 33679806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil elastase treated dendritic cells promote the generation of CD4(+)FOXP3(+) regulatory T cells in vitro.
    Tateosian NL; Reiteri RM; Amiano NO; Costa MJ; Villalonga X; Guerrieri D; Maffía PC
    Cell Immunol; 2011; 269(2):128-34. PubMed ID: 21477798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.
    Li M; Eckl J; Abicht JM; Mayr T; Reichart B; Schendel DJ; Pohla H
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction.
    Aiba S; Manome H; Yoshino Y; Tagami H
    Immunology; 2000 Sep; 101(1):68-75. PubMed ID: 11012755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies.
    Hägerbrand K; Varas L; Deronic A; Nyesiga B; Sundstedt A; Ljung L; Sakellariou C; Werchau D; Thagesson M; Gomez Jimenez D; Greiff L; Celander M; Smedenfors K; Rosén A; Bölükbas D; Carlsson F; Levin M; Säll A; von Schantz L; Lindstedt M; Ellmark P
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36323431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.
    Wu Q; Wang Y; Wang Q; Yu D; Wang Y; Song L; Liu Z; Ye X; Xu P; Cao H; Li D; Ren G
    Immunol Lett; 2016 Nov; 179():68-79. PubMed ID: 27616043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispecific Antibody Expressed by an Oncolytic Herpes Simplex Virus Type 2 Can Transform Heterologous T Cells Into Uniform Tumor Killer Cells.
    Jin J; Wang R; Yang J; Hu H; Wang D; Cai L; Fang Z; Dong S; Hu S; Wang Y; Liu B
    Hum Gene Ther; 2022 Jun; 33(11-12):649-663. PubMed ID: 35272497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of cytokines and soluble cell surface molecules by PBMC after activation with the bispecific antibody CD3 x CD19.
    Klein SC; Boer LH; de Weger RA; de Gast GC; Bast EJ
    Scand J Immunol; 1997 Nov; 46(5):452-8. PubMed ID: 9393627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis.
    Kang SE; Park JK; Yoo HJ; Kang HS; Park YW; Park BC; Park JE; Lee EY; Lee EB; Song YW
    Transl Res; 2021 Jun; 232():75-87. PubMed ID: 33453429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.